Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 36643 clinical trials
Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants

The aim of the project is to study the effects of fortification (using a Human Milk Donor Fortifier) of an exclusive preterm human milk diet on outcome of extremely preterm neonates, born at less or equal to 27 weeks.

enteral feeding
  • 0 views
  • 19 Feb, 2024
Therapeutic Recommendations for Nephroblastoma

The study is based on results form 2 previous studies carried out by the GFAOP. The aim of this study is to evaluate the capacity of units to follow the recommendations in the protocol.

wilms' tumour / nephroblastoma
  • 0 views
  • 19 Feb, 2024
Cell-free DNA in Hereditary And High-Risk Malignancies

The goal of this study is to develop an effective, sensitive blood test that can detect early tumours in patients with known or suspected hereditary cancer syndromes (HCS). If this new blood test is accurate, it could be used to screen patients for cancer and allow for earlier cancer detection.

blood test
cell-free dna
hereditary cancer
hereditary cancer syndromes
cancer
  • 0 views
  • 19 Feb, 2024
Duke Spine Outcome Study (DSOS)

The study will require obtaining spinal lesions (tumor, etc.), blood, and bone marrow samples (from non-lesional bone) from selected patients, which will be collected during your surgery.

cancer diagnosis
metastasis
metastatic disease
spinal diseases
spine surgery
  • 0 views
  • 19 Feb, 2024
Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma

P patients with acute obstructive colon cancer I resection or bridge to surgery with stent or stoma C emergency procedure O morbidity and mortality within 30 days, 90 day mortality and 3 & 5 years overall survival

colon operation
obstruction
colon resection
colon cancer
cancer
  • 0 views
  • 19 Feb, 2024
Characterization of Methylation Patterns in Cancer and Non-Cancer cfDNA

Nucleix EpiCheck tests analyzes the methylation pattern in a panel of DNA methylation biomarkers and determines whether this pattern is consistent with cancer under test or with non-cancer tissue. This study is being performed as part of the development process of the Pan Cancer EpiCheck test which includes the identification …

cancer
cfdna
  • 0 views
  • 19 Feb, 2024
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer

The BESPOKE CRC study will prospectively enroll patients who have undergone surgery for stage II or III colorectal cancer (CRC) and who have residual formalin-fixed paraffin-embedded (FFPE) tissue available will provide FFPE and whole blood samples. Patients will receive SIGNATERA test results and may be recommended for adjuvant chemotherapy or …

adenocarcinoma of the colon
formalin-fixed paraffin-embedded
adenocarcinoma of colon
adenocarcinoma
adjuvant
  • 0 views
  • 19 Feb, 2024
Study to Gather Information About the Use of Healthcare Services and the Way the Disease is Cared for in Canadian Patients With Prostate Gland Cancer Which Spread Throughout the Body

Study to gather information about the optimal placement of Ra-223 in the order of different treatments in terms of the effect on patients and in terms of the use of healthcare services for the treatment of Canadian patients with prostate gland cancer which spread to other parts of the body. …

  • 0 views
  • 19 Feb, 2024
NCI COVID-19 in Cancer Patients NCCAPS Study

This study collects blood samples, medical information, and medical images from patients who are being treated for cancer and have a positive test for SARS CoV-2, the new coronavirus that causes the disease called COVID-19. Collecting blood samples, medical information, and medical images may help researchers determine how COVID-19 affects …

cancer treatment
antibody therapy
oropharyngeal
cetuximab
antigen test
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of miRNA 371 in Patients With Germ Cell Tumors

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

germ cell cancer
tumor markers
human chorionic gonadotropin
blood product collection
gonadotropin
  • 0 views
  • 19 Feb, 2024